Stocks · Health care · Pharmaceutical Preparations

AN2 Therapeutics, Inc.

ANTX Clue Score37
United States Fiscal year ends December CIK 0001880438 Results filed 11 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Kevin Michael Krause
9 Jan 2024
Chief Strategy Officer
Sold after exercise
7,417
$20.14
$149.37K
Kevin Michael Krause
2 Jan 2024
Chief Strategy Officer
Sold after exercise
2,583
$20.12
$51.97K

What was left out

Form 4 filings counted 186
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 2
Sales at will 84
Transactions with no price 0
Shares from compensation/vesting 9,487,058
Sales filed before the plan box existed 22
History held since 31 Mar 2022